1.10. Analysis.
Comparison 1 ANY DOSE OMEGA‐3 (E‐EPA or EPA ) versus PLACEBO, Outcome 10 Adverse events: Average time to first tardive dyskinesia response.
Comparison 1 ANY DOSE OMEGA‐3 (E‐EPA or EPA ) versus PLACEBO, Outcome 10 Adverse events: Average time to first tardive dyskinesia response.